Absci (ABSI) Interest Expenses (2020 - 2026)
Absci's (ABSI) quarterly Interest Expenses came in at $18000.0 in Q1 2026, down 77.22% year-on-year from $79000.0 in Q1 2025, and down 37.93% quarter-over-quarter from $29000.0 in Q4 2025.
Absci (ABSI) Interest Expenses (2020 - 2026) Analysis & Trends
Absci has disclosed Interest Expenses across 7 years of filings, most recently posting $18000.0 for Q1 2026.
- Interest Expenses for Q1 2026 came in at $18000.0, down 77.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $148000.0 (down 68.38% YoY), and the FY2025 annual result was $209000.0, down 63.01% from the prior year.
- Interest Expenses came in at $18000.0 for Q1 2026 at Absci, down from $29000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $321000.0 in Q1 2023 to a low of $18000.0 in Q1 2026.
- The 5-year median for Interest Expenses is $176000.0 (2024), against an average of $163176.5.
- Across the five-year window, Interest Expenses tumbled 89.5% in 2022 and surged 64.62% in 2023, its largest moves.
- Absci's Interest Expenses stood at $287000.0 in 2022, then decreased by 28.92% to $204000.0 in 2023, then slumped by 46.57% to $109000.0 in 2024, then tumbled by 73.39% to $29000.0 in 2025, then tumbled by 37.93% to $18000.0 in 2026.
- The last three Interest Expenses figures came in at $18000.0 (Q1 2026), $29000.0 (Q4 2025), and $45000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 56,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | 109,000.00 |
| Dec 31, 2024 | 109,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Mar 31, 2024 | 176,000.00 |
| Mar 31, 2024 | 176,000.00 |
| Dec 31, 2023 | 204,000.00 |
| Dec 31, 2023 | 204,000.00 |